Delivery Order SPE2DB24D1104-SPE2DB25FYDN1

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.51, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medical products. This is an open competition award, with no set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...

This is a $2,319.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of April 7, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...

This is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a ceiling value of $1,582.60. The contract has a period of performance through April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication, and has a ceiling value of $1,372.80. The contract is a Firm Fixed Price type, with a period of performance through April 7, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,821.73, is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,593.20, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin product. The contract has an ultimate completion date of January 14, 2025, and utilizes a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,538.69 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication. There is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies for the provision of pharmaceutical and medical supplies, including a $999,999,999 IDC...

This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3JV7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,031.84 firm fixed-price delivery order covers the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This single-award IDC...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,877.07 and a completion date of July 8, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,277.83 contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a completion date of June 5, 2025. The award is not set aside for any specific business size or type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...